Position and Chart Updates Brief notes and Technical Chart updates on all 5 open positions. CLLS, EXPI, XON, ADAP, CDXC CLLS- $30-$31 area This has been consolidating a bit since the $38 spike price movement on the Allogene partnership news. We have said that we think in time Allogene...
XON- Intrexon $18.50 area Market Cap 2.5 Billion Website Intrexon Corporation, founded in 1998, is a leader in synthetic biology focused on collaborating with companies in human and animal health, food and agriculture, energy and chemicals, environment, and consumer products markets to create biologically based products that improve...
The rough and tumble stock market continues and we are down to 4 open positions in the TPS Portfolio. The obvious aim is to hold 6-18 months, but we also have to mind reasonable downside risk and monitor developments of companies we write reports on. Sometimes...
CLLS- $29 Recently we saw CLLS soar to $38 per share from $31 on news that Pfizer through a new private entity called Allogene Therapeutics was continuing the UCART 19 development program with Cellectis. The same day the stock soared CLLS announced a 5 million share...
The stock market continues in a Major Wave 4 correction from the 2872 highs. There is some 10-20% chance that we have entered a larger Bear cycle from 2872, if we break 2462 on the SP 500 on the downside that could trigger a move...
The Bear cycle from the 2872 highs is taking its toll across the board on Tech, Biotech etc. We are not immune. Each position should be about 8% allocation so with 5 open now it 60% TPS CASH 40% Invested The difficulty is always trying to discern...
OSTK- $40.90 Closing out position on any break of $40 per share Overstock announced last night a 4 million share offering, pricing not yet known. We expect they will raise 150 million or so, apparently another 100 million from the ICO if the SEC lets it stand. ...
ADAP $11.40 area Market Cap 1.1 Billion Investor Presentation (PDF Download Link) Recommended Reading Investors Website High of $19 per share in 2015 Cash 200 Million. Trials and Clinical work funded through mid 2020 We are a leader in the TCR T-cell therapy space focused on novel cancer immunotherapy products. We...
OSTK- near $47, recovering off 41 lows last week. Closing this out if it hits $40 per share, otherwise holding or you can buy from 41-46 This stock has been volatile obviously, first written up at $44 in the TPS service. We saw a high of $89...
35% Equity, 65% Cash in TPS Portfolio First off, I would like to apologize for lack up updates in the past week. I was unexpectedly out of town visiting my parents a few weeks ago for 9 days due to some medical issues with both of...
indian xxnx horny desi indian cheating slime wife show boobs in webcam.
